Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy [Phase 2]
Phase 2 clinical trial evaluating dalpiciclib plus fulvestrant with pyrotinib for hormone receptor-positive, HER2-low advanced breast cancer…
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating optical surface monitoring technology-guided large-segment radiotherapy for breast cancer is currently…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery [Phase 3]
A Phase 3 trial comparing higher per-day radiation therapy dose versus standard per-day dose in early-stage breast cancer after surgical rem…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer [Phase 2, Phase 3]
A multicenter randomized double-blind Phase II/III trial evaluating GM1 for prevention of peripheral neuropathy induced by albumin-bound pac…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating pyrotinib combined with trastuzumab, dalpiciclib, and letrozole for HR+/HER2+ breast cancer is ongoing w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer [Phase 2]
Phase 2 study comparing amcenestrant to physician's choice in locally advanced or metastatic estrogen receptor-positive breast cancer. The t…
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy [Phase 3]
A Phase 3 clinical trial evaluating melatonin supplementation for cancer-related fatigue in patients with breast cancer undergoing radiother…
-
CLINICAL_TRIALS research · 2023-03-30Clinical Trial Update: Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions
A completed clinical trial evaluating the Shared Decision Making Process Scale in cancer screening decisions with results posted in 2023, co…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer [Phase 2]
Phase 2 trial evaluating pegylated liposomal doxorubicin hydrochloride and carboplatin followed by surgery and paclitaxel in triple-negative…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy [Phase 3]
Phase 3 clinical trial update evaluating effectiveness and safety of Filgrastine in patients with breast cancer undergoing myelotoxic chemot…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System [NA]
A completed clinical trial evaluating opto-acoustic image quality using the Gen 2 Imagio system for breast cancer conditions; results posted…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel [Phase 3]
Phase 3 trial evaluating Neugranin in breast cancer patients receiving doxorubicin/docetaxel for chemotherapy-induced neutropenia has comple…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Pamidronate Administration in Breast Cancer Patients With Bone Metastases [Phase 4]
Phase 4 clinical trial update on pamidronate administration in breast cancer patients with bone metastases has completed.
-
CLINICAL_TRIALS research · 2023-03-28Clinical Trial Update: Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer [NA]
An active-not-recruiting trial evaluating positron emission tomography imaging in women with advanced HER2-positive breast cancer has posted…
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating adjuvant paclitaxel and trastuzumab for node-negative HER2-positive breast cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy [Phase 3]
A Phase 3 trial evaluating aspirin to prevent recurrence in node-positive HER2-negative breast cancer after standard therapy was terminated;…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. [Phase 3]
A Phase 3 trial update for HOBOE evaluating adjuvant triptorelin with tamoxifen, letrozole, or letrozole plus zoledronic acid in premenopaus…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating Vinorelbine, Carboplatin, and Trastuzumab (VinCaT) in advanced HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating neratinib with or without fulvestrant in HER2-positive, estrogen receptor-positive metastatic breast cancer has b…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy
A completed clinical trial presenting patient characteristics, treatment patterns, and clinical outcomes for HR+/HER2-negative advanced/meta…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer [Phase 1, Phase 2]
Clinical trial update for TQB3909 tablets in advanced breast cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer [Phase 2, Phase 3]
A study evaluating MRG002 for HER2-positive unresectable locally advanced or metastatic breast cancer spanning Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: UK Ibrance Patient Program (IPP) Study
Clinical trial update for the UK Ibrance Patient Program (IPP) study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging [Phase 2, Phase 3]
Clinical trial update for contrast-enhanced Cone Beam Breast CT in breast cancer under Phase 2 and Phase 3, currently terminated.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Efficacy of Cilostazol in Prevention of Peripheral Neuropathy [Phase 1, Phase 2]
A clinical trial update evaluates cilostazol for prevention of peripheral neuropathy in patients with breast cancer, spanning Phase 1 and Ph…